| Terminated | Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metfor Diabetes Mellitus, Type 2 | Phase 3 | 2017-03-03 |
| Completed | Study of the Effects of Intravenous Exenatide on Cardiac Repolarization Healthy Adult Male and Female Volunteers | Phase 1 | 2016-01-01 |
| Completed | Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Lirag Diabetes Mellitus, Type 2 | Phase 3 | 2015-12-01 |
| Completed | Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs Healthy | Phase 1 | 2015-12-01 |
| Completed | Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects Healthy Adult Premenopausal Female Volunteers | Phase 1 | 2015-12-01 |
| Completed | Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects Renal Insufficiency | Phase 1 | 2014-11-01 |
| Terminated | A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c Type 2 Diabetes | Phase 3 | 2013-05-01 |
| Completed | A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2013-05-01 |
| Completed | A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650 Type 2 Diabetes | Phase 3 | 2013-03-01 |
| Completed | A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2013-03-01 |
| Withdrawn | A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2013-02-01 |
| Withdrawn | A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2013-02-01 |
| Withdrawn | A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2013-02-01 |
| Completed | Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 2 | 2009-08-01 |
| Completed | Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes Type 2 Diabetes | Phase 1 | 2009-02-01 |
| Completed | Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment Chronic Hepatitis C | Phase 1 | 2007-08-01 |
| Terminated | Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | 2005-11-01 |
| Terminated | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | 2004-12-01 |
| Completed | Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C Hepatitis C | Phase 2 | 2004-11-01 |
| Completed | Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer Breast Neoplasms, Neoplasms, Hormone-dependent | Phase 3 | 2002-06-01 |
| Terminated | Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer Breast Cancer | Phase 3 | 2000-10-01 |